Description
Infectious virus preparation designed to meet research and product development needs.
SARS-Related Coronavirus 2 Lineage P.1; Gamma Variant (Isolate: Japan/TY7-503/2021) is an enveloped, positive-sense single-stranded RNA virus from the Coronaviridae family and the Betacoronaviridae genus. Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), isolate hCoV-19/Japan/TY7-503/2021 (Brazil P.1) (also referred to as TY7-503, hCoV19/Japan/IC-0564/2021) was isolated in airport quarantine in Japan from a COVID-19 positive passenger from Brazil in January 2021. Under the nomenclature system introduced by GISAID (Global Initiative on Sharing All Influenza Data), SARS-CoV-2, isolate hCoV19/Japan/TY7-503/2021 (Brazil P.1) is assigned lineage P.1 and GISAID clade GR using Phylogenetic Assignment of Named Global Outbreak LINeages (PANGOLIN) tool. The complete genome of SARS-CoV2, isolate hCoV-19/Japan/TY7-503/2021 (Brazil P.1) has been sequenced [Clinical isolate (referred to as hCoV19/Japan/IC-0564/2021): GISAID: EPI_ISL_792683; Passage 2 in Vero E6/TMPRSS2 cells: GISAID: EPI_ISL_877769]. Each frozen aliquot contains 1 mL of heat inactivated viral culture fluid. The culture fluid was clarified prior to heat inactivation by centrifugation to remove cellular debris. The pre-inactivation titer was determined from an infectious aliquot. Viral inactivation is verified after heat inactivation by the absence of viral growth in tissue culture-based infectivity assays.
| Certifications/Compliance | ISO 13485 |
| Content And Storage | Store at -65°C or below |
| Type | Culture Fluid |
| For Use With (Application) | Nucleic Acid-Molecular Testing, Limit of Detection (LOD) Studies, Cross-reactivity Studies, Other Viral-based Assays |
| Quantity | 1 mL |
